OS06.4A Identification of T cell receptors targeting ZFTA-RELA fusion-positive ependymoma

Niklas Kehl(German Cancer Research Center), Michael Platten(German Cancer Research Center), M Friedrich(German Cancer Research Center), Kristian W. Pajtler(German Cancer Research Center), Michael Kilian(German Cancer Research Center), Tuyu Zheng(St. Jude Children's Research Hospital), Lukas Bunse(German Cancer Research Center)
Neuro-Oncology
September 1, 2021
10.1093/neuonc/noab180.028
Cited by 0

Related Papers

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
|Cell|2016|1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
|Oncotarget|2014|309